Skip to main content
Christine Eng, MD, Medical Genetics, Houston, TX, Texas Children's Hospital

ChristineEngMD

Medical Genetics • Houston, TX

Clinical Genetics, Clinical Molecular Genetics, Pediatric Medical Genetics

Professor, Molecular & Human Genetics, Baylor College of Medicine

Join to view full profile

Dr. Eng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Eng's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai/Kravis Children's
    Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1986 - 1989
  • Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical Center
    Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1983 - 1986
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1983

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2001 - 2026
  • NY State Medical License
    NY State Medical License 1986 - 2020
  • LA State Medical License
    LA State Medical License 1983 - 1984
  • American Board of Pediatrics Pediatrics
  • American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Publisher Correction: Non-Invasive Prenatal Sequencing for Multiple Mendelian Monogenic Disorders Using Circulating Cell-Free Fetal DNA  
    Yue Wang, Arthur Beaudet, Christine M Eng, Ronald J Wapner, Sheetal Parmar, Nature
  • Clinical Exome Sequencing for Fetuses with Ultrasound Abnormalities and a Suspected Mendelian Disorder  
    Christine Eng, MD, BioMed Central
  • Clinical Exome Sequencing Reveals Locus Heterogeneity and Phenotypic Variability of Cohesinopathies  
    Scott E Hickey, Leah Slattery, James R Lupski, Margaret P Adam, Olivia Wenger, Davut Pehlivan, Laura Martin, Farida Abid, Dorothy Grange, Jennifer E Posey, Alison A Be..., Nature

Press Mentions

  • Diagnostic Laboratory Joint Venture Expands RNA Sequencing at Baylor
    Diagnostic Laboratory Joint Venture Expands RNA Sequencing at BaylorAugust 6th, 2024
  • Genetic Testing for Childhood Cancer Patients Can Identify Cause, Treatment Potential
    Genetic Testing for Childhood Cancer Patients Can Identify Cause, Treatment PotentialJanuary 28th, 2016
  • Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
    Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental DelaysSeptember 13th, 2023
  • Join now to see all

Grant Support

  • Clinical Trial: A Multicenter Open-Label Study Of Gene-Activated Human GlucocereNational Center For Research Resources2009
  • Clinical Trial: An Open-Label Extension Of Study Tkt024 Evaluating Long-Term SAFNational Center For Research Resources2008
  • Clinical Trial: A Randomized, Open-Label, Study To Assess The Safety And TolerabNational Center For Research Resources2008
  • Expanded Access Use Of Recombinant Human Acid Alpha-Glucosidase (RHGAA) (MyozNational Center For Research Resources2006–2007
  • An Open-Label Extension Of Study Tkt024 Evaluating Long-Term Safety And CliniNational Center For Research Resources2006–2007
  • Multi-Center, OPEN Label Study Of The Safety And Efficacy Of Fabrazyme In PTSNational Center For Research Resources2006
  • Iduronate-2-Sulfatase Enzyme Replacement Therapy In Patients With MPS IINational Center For Research Resources2005–2006
  • Study Of The Safety And Efficacy Of Fabrazyme In Fabry PatientsNational Center For Research Resources2005
  • Phase 2, Randomized, Open-Label, Dose Ranging, Multiple Dose Study Of Fabrazyme2National Center For Research Resources2004
  • Iduronate-2-Sulfatase Enzyme Replacement Therapy In MPSNational Center For Research Resources2004
  • Outcomes Of Genetic Testing Among Ashkenazi FamiliesNational Cancer Institute2001–2002
  • Safety &Efficacy Of Recombinant Alpha Galactosidase-ANational Center For Research Resources2000–2002
  • Recombinant Enzyme Therapy For Fabry'S DiseaseNational Center For Research Resources2000–2002
  • Enzyme Replacement Therapy For Fabry DiseaseNational Center For Research Resources1999
  • Genetic Testing In Ashkenazi Jewish PopulationNational Center For Research Resources1997

Hospital Affiliations

Dr. Christine Eng, Dr. Christine Eng, MD, Dr. C Eng